Y

Yongxin Han

Merck & Co., Inc., Rahway, NJ, USA (United States)

ORCID: 0000-0002-3014-035X

Publishes on Melanoma and MAPK Pathways, PARP inhibition in cancer therapy, Lung Cancer Treatments and Mutations. 178 papers and 4.5k citations.

PubIndex Score96Top 4%How it's scored
178Publications
4.5kTotal Citations
First publication: 1991First senior author: 1991